These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7779872)

  • 21. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro sensitivity tests for yeasts: evaluation of a micromethod].
    Rodero LL; Davel GO; Vivot W; Canteros CE; Fernández C
    Rev Argent Microbiol; 1995; 27(2):81-9. PubMed ID: 8552761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis.
    Pinto PM; Weikert-Oliveira Rde C; Lyon JP; Cury VF; Arantes RR; Koga-Ito CY; Resende MA
    Microbiol Res; 2008; 163(5):579-85. PubMed ID: 16962755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Candidemia and the susceptibility pattern of Candida isolates in blood.
    Osoba AO; Al-Mowallad AW; McAlear DE; Hussein BA
    Saudi Med J; 2003 Oct; 24(10):1060-3. PubMed ID: 14578968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Genotype, serotype and sensitivity to fluconazole of Candida albicans strains isolated from HIV-positive patients].
    Bastide JM; Pujol C; Mallié M; Reynes J
    Bull Acad Natl Med; 1999; 183(2):289-302; discussion 302-3. PubMed ID: 10371777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis.
    Rautemaa R; Richardson M; Pfaller MA; Perheentupa J; Saxén H
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):182-5. PubMed ID: 18597968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of Candida species in different hospital wards and their susceptibility to antifungal agents: results of a three year survey.
    Fadda ME; Podda GS; Pisano MB; Deplano M; Cosentino S
    J Prev Med Hyg; 2008 Jun; 49(2):69-74. PubMed ID: 18847180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: in vitro susceptibility of 375 Candida albicans isolates and biofilm production.
    Tortorano AM; Prigitano A; Biraghi E; Viviani MA;
    J Antimicrob Chemother; 2005 Oct; 56(4):777-9. PubMed ID: 16144871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility to antifungal agents of Candida species isolated from paediatric and adult patients with haematological diseases.
    Nawrot U; Nowicka J; Juszczak K; Gusin B
    Mycoses; 2005 Nov; 48(6):385-90. PubMed ID: 16262874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Candida albicans strain differentiation in complete denture wearers.
    Abu-Elteen KH
    New Microbiol; 2000 Jul; 23(3):329-37. PubMed ID: 10939048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
    Paniagua GL; Monroy E; Negrete E; Vaca S
    Rev Latinoam Microbiol; 2002; 44(2):65-8. PubMed ID: 17063773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifungal drug susceptibility of oral Candida albicans isolates may be associated with apoptotic responses to Amphotericin B.
    Yang C; Gong W; Lu J; Zhu X; Qi Q
    J Oral Pathol Med; 2010 Feb; 39(2):182-7. PubMed ID: 19656268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative in vitro antifungal susceptibility studies with 30 serotype A and B isolates of Candida albicans.
    Shadomy S; Shadomy HJ
    Diagn Microbiol Infect Dis; 1991; 14(1):21-2. PubMed ID: 2013207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B.
    Singh J; Rimek D; Kappe R
    Mycoses; 2006 Mar; 49(2):96-103. PubMed ID: 16466441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Correlation between resistance testing and typing of Candida albicans--isolates from AIDS patients and chronic recurrent oral candidiasis].
    Ruhnke M; Tennagen I; Engelmann E
    Mycoses; 1994; 37 Suppl 1():60-3. PubMed ID: 7854368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro susceptibility of Candida species isolated from blood culture to some antifungal agents.
    Citak S; Ozçelik B; Cesur S; Abbasoğlu U
    Jpn J Infect Dis; 2005 Feb; 58(1):44-6. PubMed ID: 15728993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevalence and sensitivity of Candida albicans in cultures obtained at an oncologic hospital].
    Pliego-Castañeda A; Yañez-Viguri A; López-Valle T; Valdés-de la Torre F
    Gac Med Mex; 2000; 136(3):193-9. PubMed ID: 10893847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Torulopsis glabrata. Morphologic characteristics, biotyping and sensitivity to isolates of antifungal agents in vitro].
    Pospisil J
    Cesk Epidemiol Mikrobiol Imunol; 1991 Jan; 40(1):43-8. PubMed ID: 1826472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Distribution of serotypes A and B of Candida albicans in 502 strains isolated from pathological specimens].
    Torres-Rodríguez JM; Nicolás MC; Madrenys N; Gallach C
    Med Clin (Barc); 1991 Jun; 97(1):1-3. PubMed ID: 1857140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.